Drug intelligence / Profile preview

(17s)-17-(((dimethoxyphosphoryl)methoxy)carbonyl)-3β-hydroxy-28-norurs-12(13)-ene

Development stage
Preclinical
Lead developer
Victor Babeș University of Medicine and Pharmacy Timișoara
Modality
Small Molecules
01

Overview

(17s)-17-(((dimethoxyphosphoryl)methoxy)carbonyl)-3β-hydroxy-28-norurs-12(13)-ene is a semisynthetic pentacyclic triterpenoid derivative of ursolic acid. It is part of a series of methylphosphonate-functionalized triterpenoids synthesized to improve the pharmacological profile, particularly the bioavailability and anticancer potency, of naturally occurring triterpenic acids. The compound features a dimethylphosphonate moiety attached via an ester linkage at the C-17 position. Preclinical research indicates that this derivative possesses significant antineoplastic activity, specifically demonstrating dose-dependent inhibition of cell viability and migration in melanoma cell lines such as B164A5. Compared to its parent compound, ursolic acid, this derivative is designed for enhanced therapeutic efficacy while maintaining a favorable safety profile, as evidenced by its lack of significant irritant effects in HET-CAM assays and low cytotoxicity in non-malignant models.

Other names
Ursolic acid dimethylphosphonate esterUrsolic acid methylphosphonate derivativeUA-P(OMe)2

Beyond the preview

Go deeper on (17s)-17-(((dimethoxyphosphoryl)methoxy)carbonyl)-3β-hydroxy-28-norurs-12(13)-ene.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on (17s)-17-(((dimethoxyphosphoryl)methoxy)carbonyl)-3β-hydroxy-28-norurs-12(13)-ene.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call